NL-OMON34210已完成不适用
Epidemiology of Anti-JCV Antibody Prevalence in Multiple Sclerosis Patients: JEMS - JEMS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Biogen
- 入组人数
- 190
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All candidates for this study must have the ability to understand the purpose of the study and
- •provide signed and dated informed consent.
- •All patients with a diagnosis of MS of any type, irrespective of their treatment, are eligible to
- •participate once.
排除标准
- •All candidates not able to understand the purpose of the study and not able to provide signed and dated informed consent.
研究者
相似试验
已完成
不适用
JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS)Multiple SclerosisNCT01185717Biogen7,726
撤回
不适用
Seroprevalence Study of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV) in Patients with Plakophilin 2 (PKP2)-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)ARVCheart disease10028593NL-OMON56804Tenaya Therapeutics Inc.30
招募中
不适用
Investigation of adverse reactions after COVID-19 vaccinatioJPRN-UMIN000044045ational Hospital Oraganizationa, Mie National Hospital200
进行中（未招募）
4 期
Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence AreasJapanese EncephalitisNCT06678373Liaoning Chengda Biotechnology CO., LTD250
已完成
不适用
JC-Virus (JCV) Antibody ProgramMultiple SclerosisNCT01070823Biogen1,096